Robert L. Scavo Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 5 days, 19 hours ago
Robert L. Scavo has an estimated net worth of at least $11.1 million*, as of Aug. 19, 2026. They own 487,685 shares of ALHC stock. They have sold 299,756 shares of ALHC stock since 2021, for an estimated $4.8 million.
Robert L. Scavo $ALHC SEC Form 4 Insider Trading
Robert L. Scavo has filed a total of 19 insider trades in $ALHC since 2021. Their most recent trade was a sale of 11,285 shares, made on Mar 18, 2026. Their largest trade was a sale of 65,728 shares, made on Dec 29, 2025. We estimate that they now own 487,685 shares of $ALHC, worth an estimated $6.4 million.
Insider Trading at $ALHC
There have been a total of 376 insider trades reported at $ALHC since 2021, with 217,848 shares purchased and 154.4 million shares sold. The most active insider traders in $ALHC stock have been John E Kao, Robert Thomas Freeman, and Dawn Christine Maroney. The most recent trade was a sale of 298,000 shares reported by JOHN E KAO (Chief Executive Officer), made on Aug 10, 2026.
History of Insider Stock Trades by Robert L. Scavo
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
ALHC
|
Sale | 11,285 | Mar 18, 2026 | March 19, 2026, 6:26 p.m. |
|
ALHC
|
Sale | 245 | Mar 12, 2026 | March 13, 2026, 6:32 p.m. |
|
ALHC
|
Sale | 3,799 | Mar 12, 2026 | March 13, 2026, 6:32 p.m. |
|
ALHC
|
Sale | 3,813 | Dec 29, 2025 | Dec. 30, 2025, 6:01 p.m. |
|
ALHC
|
Sale | 65,728 | Dec 29, 2025 | Dec. 30, 2025, 6:01 p.m. |
|
ALHC
|
Sale | 21,123 | Sep 10, 2025 | Sept. 10, 2025, 8:08 p.m. |
|
ALHC
|
Sale | 8,412 | Sep 10, 2025 | Sept. 10, 2025, 8:08 p.m. |
|
ALHC
|
Sale | 40,863 | Jun 11, 2025 | June 12, 2025, 5:47 p.m. |
|
ALHC
|
Sale | 60,000 | Jun 10, 2025 | June 12, 2025, 5:47 p.m. |
|
ALHC
|
Sale | 2,864 | Mar 27, 2025 | March 28, 2025, 8:30 p.m. |
|
ALHC
|
Sale | 3,923 | Mar 18, 2025 | March 19, 2025, 9:54 p.m. |
|
ALHC
|
Sale | 2,600 | Mar 19, 2025 | March 19, 2025, 9:54 p.m. |
|
ALHC
|
Sale | 4,634 | Mar 19, 2025 | March 19, 2025, 9:54 p.m. |
|
ALHC
|
Sale | 75 | Mar 12, 2025 | March 13, 2025, 5:07 p.m. |
|
ALHC
|
Sale | 5,238 | Mar 12, 2025 | March 13, 2025, 5:07 p.m. |
|
ALHC
|
Sale | 55,403 | Mar 06, 2025 | March 6, 2025, 8:35 p.m. |
|
ALHC
|
Sale | 1,821 | Mar 28, 2024 | March 29, 2024, 8 p.m. |
|
ALHC
|
Sale | 3,078 | Mar 19, 2024 | March 21, 2024, 5 p.m. |
|
ALHC
|
Sale | 4,852 | Mar 15, 2024 | March 15, 2024, 8 p.m. |
$ALHC Executives and Stock Owners with Insider Trades
-
John E Kao, Chief Executive Officer
-
Robert Thomas Freeman, Chief Financial Officer
-
Dawn Christine Maroney, President
-
Dawn Christine Maroney, President, Markets
-
Christopher J Joyce, Chief Legal and Admin. Officer
-
Dinesh M. Kumar, Chief Med & Operating Officer
-
Hyong Kim, Chief Medical Officer
-
Robert L. Scavo, Chief Information Officer
-
Hakan Kardes, Chief Experience Officer
-
Andreas P. Wagner, Chief Human Resources Officer
-
Sebastian Burzacchi, COO - Mgmt Services Org
-
Joseph S Konowiecki, Chairman of the Board
-
Dinesh M. Kumar, Chief Medical Officer
-
Richard A. Cross, SVP, General Counsel
-
Joseph S Konowiecki, EVP, Corporate Affairs
-
Donald Steven Furman, Chief Clinical Officer
-
James M Head, Chief Financial Officer
-
Mark D. Kent, President - MSO
-
Rajesh Shrestha, Pres., New Markets & CBO
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.